Goldman Sachs Group Inc Takeda Pharmaceutical CO LTD Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,628,389 shares of TAK stock, worth $62.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,628,389
Previous 4,560,807
1.48%
Holding current value
$62.7 Million
Previous $64.8 Million
5.45%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding TAK
# of Institutions
337Shares Held
68.5MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$75.8 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$57.1 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$43.9 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$41.7 Million0.06% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...